Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies

Anti-human immunodeficiency virus type 1 (HIV-1) nonneutralizing antibodies (nnAbs) capable of antibody-dependent cellular cytotoxicity (ADCC) have been identified as a protective immune correlate in the RV144 vaccine efficacy trial. Broadly neutralizing antibodies (bNAbs) also mediate ADCC in cell...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Virol
Asıl Yazarlar: Bruel, Timothée, Guivel-Benhassine, Florence, Lorin, Valérie, Lortat-Jacob, Hugues, Baleux, Françoise, Bourdic, Katia, Noël, Nicolas, Lambotte, Olivier, Mouquet, Hugo, Schwartz, Olivier
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2017
Konular:
Vaccines and Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5375671/
https://ncbi.nlm.nih.gov/pubmed/28122982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02440-16
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller